Annual report
3825.TEDINET S100TW6O
Period2023-04-01 → 2024-03-31
Filed2024-06-27
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 150
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥20.5bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥32.8bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥28.8bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥13.2bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥11.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥1.7bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | −¥1.9bn | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥1.8bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥1.7bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥8.2bn | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥2.9bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.2bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.0bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥7.3bn | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.1bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.3bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥6.9bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥3.0bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥5.2bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.1bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥3.3bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥19.7bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥19.3bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥73.0bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥47.6bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥14.3bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.7bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥2.4bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥18.0bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥16.8bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥14.1bn | at 2022-03-31d | Cons. | Net assets |
| Net assets / equity | ¥4.3bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥3.9bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥13.6bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥11.2bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥13.6bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.2bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.9bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥2.8bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥2.4bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥6.8bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥429m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥3.1bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥3.8bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥120m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥13.7bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥259m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥203m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥674m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥164m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥564m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥2.7bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥3.4bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥746m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥8.98 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.32 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥64.05 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-36.86 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-88.66 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥8.98 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥27.17 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥63.26 | 2021-04-01 → 2022-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥149.32 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥141.75 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥121.03 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥43.76 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥62.86 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 91.1% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 87.3% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 19.3% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 9.0% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.8% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 6.2% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 21.1% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 75.2% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | -73.3% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | -85.9% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 256 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 147 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 199 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 181 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 151 | at 2020-03-31d | Cons. | Number of employees |
| Revenue | ¥20.2bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥31.9bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥18.4bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥11.7bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥10.4bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.7bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | −¥1.9bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | ¥3.7bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥4.1bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.5bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥2.4bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥100m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥3.0bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥4.1bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | ¥3.0bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥4.1bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥1.2bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥2.5bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥4.0bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥17.4bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥14.7bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥11.4bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥9.2bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥5.4bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.1bn | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥1.4bn | at 2023-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥16.4bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥13.3bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥9.8bn | at 2022-03-31d | Standalone | Net assets |
| Net assets / equity | ¥5.7bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥4.7bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥11.5bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥6.5bn | at 2023-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥25.25 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥34.21 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥11.28 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-30.58 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-68.75 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥25.24 | 2023-04-01 → 2024-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥34.02 | 2022-04-01 → 2023-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥11.14 | 2021-04-01 → 2022-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥2 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥136.02 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥111.93 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥83.57 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥57.31 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥76.41 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 93.8% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.2% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 85.1% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.9% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 86.7% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 20.3% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 35.6% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 15.9% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | -48.0% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | -64.0% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 122,727,800 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 122,717,800 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 116,530,700 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 98,254,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 60,917,600 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 125 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 147 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 154 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 128 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 95 | at 2020-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 74
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | employees | at 2024-03-31 | 1 pure |
| Reconciling Itemsreconciling | capex | 2023-04-01 → 2024-03-31 | ¥5m |
| Reconciling Itemsreconciling | depreciation | 2023-04-01 → 2024-03-31 | ¥22m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2024-03-31 | −¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2024-03-31 | −¥1m |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥12.4bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2024-03-31 | −¥701m |
| Energy Businessreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥34m |
| Energy Businessreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥20m |
| Energy Businessreportable segment | employees | at 2024-03-31 | 58 pure |
| Energy Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥18.9bn |
| Energy Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥18.9bn |
| Energy Businessreportable segment | segment assets | at 2024-03-31 | ¥4.2bn |
| Energy Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥2.3bn |
| Medical Businessreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥2m |
| Medical Businessreportable segment | employees | at 2024-03-31 | 131 pure |
| Medical Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥279m |
| Medical Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥278m |
| Medical Businessreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥1m |
| Medical Businessreportable segment | segment assets | at 2024-03-31 | ¥639m |
| Medical Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | −¥7m |
| Other Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥102m |
| Other Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥102m |
| Other Businessreportable segment | segment assets | at 2024-03-31 | ¥1.8bn |
| Other Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥24m |
| Resilience Businessreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥2m |
| Resilience Businessreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥6m |
| Resilience Businessreportable segment | employees | at 2024-03-31 | 47 pure |
| Resilience Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥1.2bn |
| Resilience Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥1.2bn |
| Resilience Businessreportable segment | segment assets | at 2024-03-31 | ¥677m |
| Resilience Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥131m |
| —segment total | capex | 2023-04-01 → 2024-03-31 | ¥37m |
| —segment total | depreciation | 2023-04-01 → 2024-03-31 | ¥29m |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥20.5bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥20.5bn |
| —segment total | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥1m |
| —segment total | segment assets | at 2024-03-31 | ¥7.3bn |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | ¥2.4bn |
| Reconciling Itemsreconciling | capex | 2022-04-01 → 2023-03-31 | ¥35m |
| Reconciling Itemsreconciling | depreciation | 2022-04-01 → 2023-03-31 | ¥19m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2023-03-31 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥0 |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | ¥7.8bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2023-03-31 | −¥1.1bn |
| Energy Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥68m |
| Energy Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥19m |
| Energy Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥25.3bn |
| Energy Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥25.3bn |
| Energy Businessreportable segment | segment assets | at 2023-03-31 | ¥5.4bn |
| Energy Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥491m |
| Other Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥170m |
| Other Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥227m |
| Other Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥6.9bn |
| Other Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥6.9bn |
| Other Businessreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥0 |
| Other Businessreportable segment | segment assets | at 2023-03-31 | ¥5.9bn |
| Other Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥49m |
| Resilience Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥26m |
| Resilience Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥2m |
| Resilience Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥637m |
| Resilience Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥637m |
| Resilience Businessreportable segment | segment assets | at 2023-03-31 | ¥253m |
| Resilience Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥162m |
| —segment total | capex | 2022-04-01 → 2023-03-31 | ¥265m |
| —segment total | depreciation | 2022-04-01 → 2023-03-31 | ¥249m |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥32.8bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥32.8bn |
| —segment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥0 |
| —segment total | segment assets | at 2023-03-31 | ¥11.5bn |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | −¥703m |
| Otherother segments | employees | at 2024-03-31 | 1 pure |
| Energy Businessreportable segment | employees | at 2024-03-31 | 58000 pure |
| Resilience Businessreportable segment | employees | at 2024-03-31 | 47 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,478
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)アスカ監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)若 尾 典 邦 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)小 原 芳 樹 | |
| Key audit matters consolidated (text) | FilingDateInstant | Text · Plus | |
| Overview kam consolidated (text) | FilingDateInstant | Text · Plus | |
| Short description kam consolidated | FilingDateInstant_Row1Member | Original text (Japanese)株式会社ゼロメディカルに係るのれんの評価 | |
| Description including reason kam consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Auditors response kam consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Other information consolidated (text) | FilingDateInstant | Text · Plus | |
| Fee related information consolidated (text) | FilingDateInstant | Text · Plus | |
| Independent auditors report non consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)アスカ監査法人 | |
| Cpa1 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)若 尾 典 邦 | |
| Cpa2 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)小 原 芳 樹 | |
| Key audit matters non consolidated (text) | FilingDateInstant | Text · Plus | |
| Overview kam non consolidated (text) | FilingDateInstant | Text · Plus | |
| Short description kam non consolidated | FilingDateInstant_Row1Member | Original text (Japanese)関係会社株式（ゼロメディカル）の評価 | |
| Same as kam for consolidated fskam non consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Other information non consolidated (text) | FilingDateInstant | Text · Plus | |
| Fee related information non consolidated (text) | FilingDateInstant | Text · Plus | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior4YearDuration | 11229000000 | JPY |
| Net sales (5-year summary) | Prior3YearDuration | 13217000000 | JPY |
| Net sales (5-year summary) | Prior2YearDuration | 28753000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 32789000000 | JPY |
| Net sales (5-year summary) | CurrentYearDuration | 20487000000 | JPY |
| Ordinary income loss (5-year summary) | Prior4YearDuration | -1231000000 | JPY |
| Ordinary income loss (5-year summary) | Prior3YearDuration | -2893000000 | JPY |
| Ordinary income loss (5-year summary) | Prior2YearDuration | 8173000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | -1722000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYearDuration | 1758000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior4YearDuration | -5173000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior3YearDuration | -2974000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior2YearDuration | 6913000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 3267000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYearDuration | 1070000000 | JPY |
| Comprehensive income (5-year summary) | Prior4YearDuration | -5173000000 | JPY |
| Comprehensive income (5-year summary) | Prior3YearDuration | -2974000000 | JPY |
| Comprehensive income (5-year summary) | Prior2YearDuration | 6913000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 3267000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYearDuration | 1070000000 | JPY |
| Net assets (5-year summary) | Prior4YearInstant | 3870000000 | JPY |
| Net assets (5-year summary) | Prior3YearInstant | 4322000000 | JPY |
| Net assets (5-year summary) | Prior2YearInstant | 14114000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 16826000000 | JPY |
| Net assets (5-year summary) | CurrentYearInstant | 17969000000 | JPY |
| Total assets (5-year summary) | Prior4YearInstant | 14259000000 | JPY |
| Total assets (5-year summary) | Prior3YearInstant | 47556000000 | JPY |
| Total assets (5-year summary) | Prior2YearInstant | 72968000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |